Rhythm Pharmaceuticals excels in rare genetic obesity treatments with innovative therapies, market potential, and growth opportunities. Learn more on RYTM stock here.

A family in Napton have set up a fundraising page to help buy specialist equipment for their nine-year-old daughter who has ...

Our list of the best movies on Disney Plus is a lot more varied than you might think! Disney is best known as the home of ...

When it comes to picking the healthiest cereal options, ancient grain in cereal have been stealing the spotlight lately. But ...

Here we dive into how a self-made entrepreneur now earns more than when she had a boss -- find out how you can, too.

Grandmother explains how distraught she is knowing her granddaughter Esmay Ford won't live long after being diagnosed with a ...

Scientists in Japan have used gene-editing technology to remove the extra chromosome responsible for Down syndrome, at least ...

Of the 258 participants, 195 were cognitively asymptomatic, 34 had mild cognitive impairment, 23 had dementia, and six had an ...

Hannah, who is 18 years old, graduated from Bernalillo High School this year. She has Down syndrome. To the surprise of many, ...

Eggs and embryos from people with polycystic ovary syndrome have altered patterns of so-called epigenetic tags, which could ...

In December, the first human chromosome - chromosome 22 - and its DNA was completely mapped. But experts say chromosome 21 - the smallest human chromosome - holds more potential because it is ...

There are plenty of UK shares that look well-placed to beat the mid-cap index over the next few years. Here's one FTSE stock down 66% that I like. The post 1 stock from the FTSE 250 that could be set ...